COVID-19 Serotherapy [sérologická léčba covidu-19]
- Terms
-
léčba covid-19 hyperimunními globuliny
léčba COVID-19 rekonvalescentní plazmou
léčba covid-19 rekonvalescentním sérem
léčba covidu-19 hyperimunními globuliny
léčba covidu-19 rekonvalescentní plazmou
léčba covidu-19 rekonvalescentním sérem
-
Convalescent Plasma Treatment for Covid-19
Convalescent Serum Treatment for Covid-19
Coronavirus Disease 2019 Serotherapy
Coronavirus Disease-19 Serotherapy
COVID-19 Convalescent Plasma Treatment
Covid-19 Convalescent Sera Treatment
COVID-19 Convalescent Serum Treatment
COVID-19 Hyperimmune Globulin Therapy
COVID-19 Serum Therapy
COVID19 Hyperimmune Globulin Therapy
COVID19 Serotherapy
COVID19 Serum Therapy
Hyperimmune Globulin Therapy for COVID-19
SARS-CoV-2 Convalescent Plasma Treatment
SARS-CoV-2 Convalescent Sera Treatment
SARS-CoV-2 Convalescent Serum Treatment
Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts.
- DUI
- D000093522 MeSH Browser
- CUI
- M000754225
- History note
- 2023 (2020)
- Public note
- 2023; COVID-19 SEROTHERAPY was indexed under COVID-19 2020-2022, and IMMUNIZATION, PASSIVE 2020-2022
Allowable subheadings
- AE
- adverse effects
- CL
- classification
- EC
- economics
- ES
- ethics
- HI
- history
- IS
- instrumentation
- MT
- methods
- MO
- mortality
- NU
- nursing
- PX
- psychology
- ST
- standards
- SN
- statistics & numerical data
- TD
- trends
- VE
- veterinary